Break through with differentiation, steer with steadiness, transform for profitability
PwC has deepened its expertise in China’s pharmaceutical and life sciences sector. By seamlessly integrating global perspectives with local insights, we empower our industry clients to achieve high-quality growth and steady advancement amid waves of innovation-driven change, regulatory transformation, and global expansion.
We deeply understand the evolving trends in China’s pharmaceutical and life sciences industry—transitioning from “traditional development models” to “pharmaceutical innovation system upgrades,” “clinical R&D ecosystem reshaping,” “digital R&D and smart manufacturing advancement,” and “compliance and capital management optimisation.”
Leveraging our global resources and cross-industry network, PwC delivers end-to-end professional services. We support pharmaceutical companies, biotech firms, medical device manufacturers, and investment institutions with solutions spanning strategic planning, innovation management, operational optimisation, risk and compliance, capital operations, and sustainable governance. This enables our clients to stay ahead of the curve, unlock sustained growth potential, and build new core competencies.
PwC’s pharmaceutical and life sciences team spans global markets. Leveraging deep industry experience and systematic execution capabilities, they collaborate closely with leading pharmaceutical and life sciences clients globally. Beyond professional consulting, they actively engage in co-creation of value with clients.
Through long-term partnerships with Chinese Mainland clients, PwC has helped accelerate innovation commercialisation, enhance supply chain synergy, strengthen quality and compliance management, and build sustainable growth models that deliver both scientific and societal value. Simultaneously, by driving strategy with insights, empowering development with technology, and safeguarding lives with expertise, PwC has supported China’s pharmaceutical and life sciences sector in transitioning from “industrial catch-up” to “innovation leadership” within the global innovation landscape. This has solidified the foundation for building differentiated core competitiveness.
We understand your industry. We know the challenges you face across your value chain. Our specialists advise policymakers, providers and payers. We support pharma, biotech and medical device businesses.Our actionable insights—from strategic decision-making to regulation and compliance—enable time-critical implementation.
The pharmaceutical industry strides toward value-based sustainable growth amid fierce competition and rising clinical needs. Leveraging in-depth industry insights and global proven practices, we provides customised strategy and growth solutions. We focus on business model innovation, competition research and channel layout, helping clients optimise positioning, expand high-value businesses, fuel steady growth and secure long-term market advantages.
Industry upgrading fuels vigorous consolidation and standardised capital operations. With rich transaction experience and global resources, we offer one-stop merger and acquisition services covering target selection, due diligence, valuation and post-deal integration. We help clients lower risks, maximise transaction value, achieve business synergy, support capital layout and deliver lasting shareholder returns.
Pharmaceutical companies strive to boost efficiency and operational resilience amid cost challenges and stricter compliance rules. We deliver tailored lean operation and supply chain solutions focusing on inventory optimisation, logistics upgrading, quality control and compliance certification. We assist clients in cutting costs, improving operational performance and maintaining stable compliant operations.
Industrial innovation calls for complete commercial systems to unlock product market value. Supported by solid market access experience, we offer full-cycle commercial services including market planning, business drafting, product launch and sales improvement. Support clients accelerate sales growth, expand market coverage, raise product profits and build lasting commercial strengths.
Updated industry rules drive companies to build solid compliance systems for business development. Equipped with full regulatory expertise and compliance systems, we provide all-round risk control services covering policy research, system building, internal audit and data security management. We ensure client with full policy compliance, avoid operational and legal risks and guarantee stable business development.
Rapid industrial iteration pushes companies to upgrade organisation and talent systems to sharpen core competitiveness. Drawing on rich transformation experience, we provide holistic organisational and talent upgrading services. By optimising talent planning and institutional structure, we help clients build efficient and flexible teams to underpin long-term corporate development.
Digital and intelligent technology acts as core driving force for pharmaceutical industrial upgrading. Combining advanced tech strengths and practical industry experience, we design exclusive digital and intelligent transformation plans including system construction, data analysis and standardised data management. We empower intelligent business upgrading, lift overall efficiency and capture digital development opportunities.
Industrial expansion demands standardised and refined financial management for solid business support. Based on global financial management experience, we offer professional financial transformation and governance services covering financial planning, shared service construction and tax risk control. We help clients realise refined financial management, optimise resource allocation, reduce financial risks and consolidate solid financial foundations.